In this weeks video, Dr. Brian G.M. Durie explains how the ARROW study demonstrated efficacy and low toxicity for weekly dosing of carfilzomib.
BOTTOM LINE: Ensure your doctor is aware of the ARROW study in order to consider once-weekly dosing of carfilzomib.